Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma

Published:2018-02 Issue:2 Volume:26 Page:366-378
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Yu Min,Luo Hong,Fan Mingliang,Wu Xiuqi,Shi Bizhi,Di Shengmeng,Liu Ying,Pan Zeyan,Jiang Hua,Li Zonghai

Funder

Shanghai Science and Technology Innovation Action Plan

Collaborative Innovation Center for Translational Medicine at Shanghai Jiao Tong University School of Medicine

Renji Hospital

Shanghai Science and Technology Development Funds

State Key Laboratory of Oncogenes and Related Genes

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference37 articles.

1. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma;Maluccio;CA Cancer J. Clin.,2012

2. Functions of natural killer cells;Vivier;Nat. Immunol.,2008

3. Natural killer cells in liver disease;Tian;Hepatology,2013

4. A new approach to the therapy of cancer based on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2;Rosenberg;Surgery,1986

5. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer;Rosenberg;N. Engl. J. Med.,1985

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NK cell-based immunotherapy in hepatocellular carcinoma: An attractive therapeutic option for the next decade;Cellular Signalling;2024-12

2. Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment;Frontiers in Immunology;2024-09-03

3. Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells;Cell Stem Cell;2024-09

4. Antitumor effects of natural killer cells derived from gene-engineered human induced pluripotent stem cells on hepatocellular carcinoma;2024-08-13

5. Development of TSHR-CAR NK-92 cells for Differentiated Thyroid Cancer;Molecular and Cellular Endocrinology;2024-08